Investec Bank Plc purchased 345,456 ordinary shares in Advanced Medical Solutions Group Plc on 12th November 2026, according to a regulatory filing made the following day.
The purchases were executed at prices ranging from 282.561 pence to 283 pence per share, reflecting tight pricing across the transaction.
On the same date, Investec also sold 200,301 ordinary shares in the company, with both the highest and lowest recorded sale price standing at 283 pence per unit.
The net position across both legs of the activity represents a significant volume of shares changing hands through the bank’s client-serving trading desk in a single session.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs dealings by exempt principal traders operating with recognised intermediary status acting in a client-serving capacity.
Investec holds a dual role in relation to Advanced Medical Solutions Group Plc, serving simultaneously as the company’s financial adviser and joint broker during the current offer period.
That relationship requires Investec to publicly disclose any share dealings it conducts in the target company’s securities, regardless of whether those trades are proprietary or client-driven.
The filing confirmed that no cash-settled derivatives, stock-settled derivatives, or options were transacted as part of the disclosed activity on that date.
Investec also stated that no indemnity arrangements, options agreements, or any formal or informal understandings relating to voting rights or future acquisitions are in place in connection with the offer.
Advanced Medical Solutions Group Plc is a UK-listed medical device and wound care company whose shares have attracted regulatory scrutiny consistent with an active offer period under Takeover Panel oversight.
The disclosure was filed with a Regulatory Information Service as required under the Code, with contact details attributed to Abhishek Gawde for any follow-up inquiries related to the submission.
Shares in Investec Bank Plc traded down 1.24% on the London Stock Exchange under the ticker INVP.L on the day the disclosure was published.
